Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 33 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-24 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +30,000 30,000
2025-06-25 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +30,000 30,000
2024-08-26 Thompson Peter A. Director Sale −83,695 $13.00 $1.1M 0
2024-08-23 Thompson Peter A. Director Sale −69,500 $13.03 $906K 83,695
2024-08-22 Thompson Peter A. Director Sale −391,482 $12.94 $5.1M 153,195
2024-08-21 Thompson Peter A. Director Sale −394,400 $13.52 $5.3M 557,977
2024-08-21 Thompson Peter A. Director Sale −13,300 $14.61 $194K 544,677
2024-06-20 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-08-29 Thompson Peter A. Director Purchase +500,000 $6.20 $3.1M 8,019,187
2023-06-27 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2022-06-10 Thompson Peter A. Director Grant or award · Stock Option (right to buy) +18,000 18,000

Page 1 of 1 · 11 trades